The global 3D bioprinting market is projected to reach a value of $792.5 million in 2022, witnessing a CAGR of 35.9% during the forecast period (2016–2022). The market is registering growth due to the high demand for tissues and organs for transplantation, technological advancements and innovations, and rising compliance for drug discovery processes. 3D bioprinting is an additive manufacturing technology and refers to the process of creating 3D structures by making use of live cells. The process utilizes 3D printing technologies for creating live tissue or cell structures.
Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample
When application is taken into consideration, the 3D bioprinting market is divided into pharmaceutical, tissue & organ regeneration, 3D cell culture, and others. Out of these, the tissue & organ regeneration application dominated the market during the historical period and is further predicted to account for the largest revenue share of more than 55.0% in 2022. The 3D cell culture category is expected to witness the fastest growth during the forecast period. This is because extensive research is being carried out in the field of stem cell around the world.
Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=3d-bioprinting-market
The rising compliance for drug discovery processes is a major driving factor of the 3D bioprinting market. Several drugs are not given approval by regulatory authorities because of their toxicity to certain organs, which cannot be predicted during the pre-clinical trial process. However, tissues developed through 3D bioprinting, including liver tissue, help in predicting drug toxicity and improving drug efficacy. 3D bioprinting also saves time during clinical trials. Because of these factors, several pharmaceutical companies are collaborating with 3D bioprinting companies for testing their drugs during the early stage of clinical trials.
Hence, the market is expanding due to the growing compliance for drug delivery processes and increasing demand for tissues and organs for transplantation.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
This release was published on openPR.